2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial

BACKGROUND: The noninferiority of pH-dependent release mesalamine (Asacol) once daily (QD) to 3 times daily (TID) administration was investigated. METHODS: This was a phase 3, multicenter, randomized, double-blind, parallel-group, active-control study, with dynamic and stochastic allocation using ce...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Inflamm Bowel Dis
Hlavní autoři: Suzuki, Yasuo, Iida, Mitsuo, Ito, Hiroaki, Nishino, Haruo, Ohmori, Toshihide, Arai, Takehiro, Yokoyama, Tadashi, Okubo, Takanori, Hibi, Toshifumi
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2017
Témata:
Original Clinical Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404402/
https://ncbi.nlm.nih.gov/pubmed/28368909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000001065
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky